Search

Your search keyword '"Jakschies, D."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Jakschies, D." Remove constraint Author: "Jakschies, D."
29 results on '"Jakschies, D."'

Search Results

1. Onkologie III: Grundlagen

3. Abstract

7. Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells

8. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

9. Interferon-α resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells

15. Interferon-alpha resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells.

16. Interferon-α resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription I which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood...

17. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus.

18. Effective Natural Interferon-α Therapy in Recombinant Interferon-α-Resistant Patients With Hairy Cell Leukemia

19. Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia.

20. Different specificities of SLE-derived and therapy-induced interferon-alpha antibodies.

21. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C.

22. Correlation of the antiproliferative effect and the Mx-homologous protein induction by IFN in patients with malignant melanoma.

23. The human intracellular Mx-homologous protein is specifically induced by type I interferons.

24. Emergence and decay of the human Mx homolog in cancer patients during and after interferon-alpha therapy.

25. The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection.

27. Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.

29. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.

Catalog

Books, media, physical & digital resources